HSBC Holdings
FLGT icon

HSBC Holdings’s Fulgent Genetics FLGT Stock Holding History

HSBC Holdings’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,800
Closed -$255K – 3288
2021
Q3 		$255K Buy
+2,800
New +$254K ﹤0.01% 2637

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HSBC Holdings's FLGT Position: Q2 2026 in Review

HSBC Holdings reduced its Fulgent Genetics (FLGT) stake by 31% in Q2 2026, selling an estimated $341K and leaving 45,048 shares worth $915K. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

HSBC Holdings first reported a position in FLGT in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.79M in Q1 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • HSBC Holdings held 45,048 shares of Fulgent Genetics worth $915K as of Q2 2026.
  • HSBC Holdings sold 20,126 Fulgent Genetics shares in Q2 2026, an estimated $341K.
  • Fulgent Genetics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1994 holding.
  • HSBC Holdings first reported a position in Fulgent Genetics in Q1 2021 and has held it in 18 quarters since.
  • HSBC Holdings's Fulgent Genetics position peaked at $1.79M in Q1 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.